Edition:
United States

TearLab Corp (TLB.TO)

TLB.TO on Toronto Stock Exchange

1.66CAD
12:29pm EDT
Change (% chg)

$-0.09 (-5.14%)
Prev Close
$1.75
Open
$1.65
Day's High
$1.66
Day's Low
$1.65
Volume
900
Avg. Vol
9,770
52-wk High
$10.10
52-wk Low
$1.55

Latest Key Developments (Source: Significant Developments)

TearLab corp - files for offering of up to $15 million - SEC filing‍​
Monday, 21 Aug 2017 05:21pm EDT 

Aug 21 (Reuters) - Tearlab Corp :TearLab Corp - files for offering of up to $15 million - SEC filing‍​.TearLab- offering consists of Class A units consisting of common stock,warrants & Class B units consisting series a convertible preferred stock,warrants.  Full Article

TearLab Corporation Q2 loss per share $0.68
Monday, 14 Aug 2017 04:01pm EDT 

Aug 14 (Reuters) - Tearlab Corp :TearLab Corporation reports second quarter and first half 2017 financial results.Q2 loss per share $0.68.Q2 revenue $7.0 million.TearLab Corp - expects to file its application for clearance of TearLab Discover System, with U.S. Food and Drug Administration in second half of 2017.TearLab Corp - for balance of Q3 2017 and into Q4 2017, company will be taking necessary steps to complete a capital raise.  Full Article

Tearlab announces European regulatory clearance for Tearlab Discovery System
Friday, 21 Jul 2017 07:00am EDT 

July 21 (Reuters) - Tearlab Corp :Tearlab announces European regulatory clearance for next-generation Tearlab Discovery System.  Full Article

TearLab receives Nasdaq listing extension
Wednesday, 21 Jun 2017 05:41pm EDT 

June 21 (Reuters) - TearLab Corp -:TearLab Corp - on June 19, nasdaq hearings panel granted co's request for continued listing, pursuant to extension, through October 6, 2017.  Full Article

Tearlab Corp reports Q1 loss per share of $0.82
Monday, 15 May 2017 04:05pm EDT 

May 15 (Reuters) - Tearlab Corp :Tearlab Corp reports first quarter 2017 financial results.Q1 loss per share $0.82.Q1 earnings per share view $-0.75 -- Thomson Reuters I/B/E/S.Expects to file application for clearance of next generation device, including all three biomarkers, with U.S. FDA by end of Q3.Qtrly net revenues were $6.7 million, compared with $6.8 million for same period in 2016.  Full Article

TearLab osmolarity system receives Brazilian regulatory approval
Friday, 12 May 2017 07:30am EDT 

May 12 (Reuters) - TearLab Corp -:TearLab Osmolarity system receives brazilian regulatory approval.Says approval allows tearlab to begin selling product to aid in diagnosis of dry eye disease (ded) in brazilian market.TearLab Corp - received approval for tearlab osmolarity system from agência nacional de vigilância sanitária in brazil.TearLab Corp - the approval allows tearlab to begin selling product to aid in diagnosis of dry eye disease in brazilian market.  Full Article

Tearlab Corp Q4 loss per share $0.81
Thursday, 9 Mar 2017 04:01pm EST 

Tearlab Corp : Tearlab Corporation reports fourth quarter and year end 2016 financial results . Q4 loss per share $0.81 . Q4 revenue $7.1 million versus I/B/E/S view $7.6 million .Q4 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.  Full Article

Tearlab's In-Vitro diagnostics testing platform got CE marking of device
Monday, 6 Mar 2017 05:20pm EST 

Tearlab Corp :Co's In-Vitro diagnostics testing platform got CE marking of device.  Full Article

Tearlab announces 1-for-10 reverse split of common stock
Friday, 24 Feb 2017 08:00am EST 

Tearlab Corp : Tearlab announces 1-for-10 reverse split of common stock .Says 1-for-10 reverse stock split will be effective as of close of business on Friday, February 24.  Full Article

TearLab files for offering of up to 12,535,000 shares of common stock underlying warrants
Friday, 3 Feb 2017 05:18pm EST 

TearLab Corp :Files for offering of up to 12,535,000 shares of common stock underlying warrants.  Full Article

BRIEF-TearLab corp - files for offering of up to $15 million - SEC filing‍​

* TearLab Corp - files for offering of up to $15 million - SEC filing‍​